MD Anderson Events
Prevention of Chemotherapy-induced Cardiotoxicity
To identify opportunities for cardio-protection from perspectives of sarcoma, leukemia, breast cancer, and pediatric patients.
To predict patient’s susceptibility to develop cardiotoxicity before chemotherapy and strategies for PRIMARY PREVENTION.
To discuss strategies for SECONDARY PREVENTION after chemotherapy-induced changes in biomarkers and echo.
To discuss the potential for cessation of heart failure therapy and strategy for long-term follow up.
Date: 11/15/13, 8am to 12:30pm
Time: 11/15/13, 8am to 12:30pm
Location: Pickens Academic Tower, Telehealth Videoconference Room, FCT3.5001
CME: Physicians may claim AMA PRA Category 2 Credit(s)™ for viewing the workshop. Physicians should self-claim credit to the AMA on their AMA PRA certificate application form.
Contact: Amy Heaton - (713) 745-6826 - email@example.com